Futura Medical plc (FUM.L)

GBp 32.6

(-0.15%)

Market Cap (In GBp)

99 Million

Revenue (In GBp)

3.1 Million

Net Income (In GBp)

-6.51 Million

Avg. Volume

390.64 Thousand

Currency
GBp
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
21.5-47.8
PE
-
EPS
-
Beta Value
1.265
ISIN
GB0033278473
CUSIP
G3698F100
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. James Henry Barder
Employee Count
-
Website
https://www.futuramedical.com
Ipo Date
2003-07-22
Details
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel. The company was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.

More Stocks